FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

1197376005: Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4696126011 Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4696127019 Ethambutol hydrochloride 275 mg and isoniazid 75 mg and pyrazinamide 400 mg and rifampicin 150 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4696128012 Ethambutol hydrochloride 275 mg and isoniazid 75 mg and pyrazinamide 400 mg and rifampin 150 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5638951000052116 etambutolhydroklorid 275 mg, isoniazid 75 mg, pyrazinamid 400 mg och rifampicin 150 mg, oral tablett sv Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Is a Ethambutol and isoniazid and pyrazinamide and rifampicin only product in oral dose form true Inferred relationship Some
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form Oral tablet true Inferred relationship Some
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Plays role Antitubercular therapeutic role true Inferred relationship Some
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Ethambutol hydrochloride true Inferred relationship Some 1
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Ethambutol hydrochloride true Inferred relationship Some 1
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 1
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Pyrazinamide (substance) true Inferred relationship Some 2
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Pyrazinamide (substance) true Inferred relationship Some 2
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 2
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 2
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Rifampicin true Inferred relationship Some 3
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Rifampicin true Inferred relationship Some 3
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 3
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 3
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient Isoniazid (substance) true Inferred relationship Some 4
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) Isoniazid (substance) true Inferred relationship Some 4
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit mg true Inferred relationship Some 4
Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and pyrazinamide 400 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 4

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start